Search Results 391-400 of 24167 for In situ

1. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

   Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer ... situ of the uterine cervix which has ...

2. Study of Metabolic, Phenotypic and Microbiome Profiling in Fetal Tracheal Aspirate and Amniotic Fluid after Fetal Surgery - Mayo Clinic

   Results by fluorescence in situ hybridization (FISH) will be acceptable if the patient is > 26weeks. Isolated Left CDH with liver up. Gestation age at ...

3. Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving ...

4. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy ... in-situ of the ...

5. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

   ... in situ or other stable, relatively benign carcinomas). Known substance abuse in the year before Screening. Chronic use (≥ 12 months) of drugs historically ...

6. Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer - Mayo Clinic

   ... in-situ of the cervix; NOTE: if there is a history of prior malignancy, patients must not be receiving other specific treatment (chemotherapy, hormonal ...

7. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

   EXCEPTIONS: Non-melanotic skin cancers or carcinoma-in-situ of the cervix. Copanlisib is primarily metabolized by CYP3A4; therefore, the concomitant use of ...

8. A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

   ... in Adult Participants With Previously Treated Non-Squamous Non-Small Cell ... * Adequately treated carcinoma in situ without current evidence of disease.

9. Phase 3 Study to Treat Patients with Soft Tissue Sarcomas - Mayo Clinic

   ... in situ, superficial bladder cancer or carcinoma in situ of the cervix unless documented free of cancer for ≥5 years. Laboratory values: Screening serum ...

10. An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... in malignant lymphoma (Cheson, 2014) non-Hodgkin ... situ cervical carcinoma, or any other tumor that ... in the protocol or other uncontrolled infections